Sponsored By:
Host: Chris Anderson, EIC, Clinical OMICs Guest: Dr. Sandip Patel, Medical Oncologist, University of California, San Diego In this episode Chris Anderson and Dr. Sandip Patel will examine the growing number of treatments targeted at specific molecular profiles including how broad-based, pan-cancer testing can uncover less prevalent mutations, such as NTRK fusions, which can be targeted by approved therapies, even though these are only predominant in less than 1 percent of cancer cases.
